
Broad-Based Technical Strength Lifts Trident Lifeline Ltd to 52-Week High of Rs 412.2
2026-09-22 09:51:10Surging past its previous peaks, Trident Lifeline Ltd reached a fresh 52-week high of Rs 412.2 on 22 Sep 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained buying interest, setting the stage for a compelling momentum narrative.
Read full news article
Trident Lifeline Ltd Valuation Shifts Signal Changing Market Sentiment
2026-09-22 08:01:38Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group.
Read full news article
Strong Momentum Meets Stretched Valuations as Trident Lifeline Ltd Reaches All-Time High
2026-09-21 11:33:33Extending its winning streak to four consecutive sessions, Trident Lifeline Ltd surged to a fresh all-time high of Rs 333 on 21 Sep 2026, outperforming its sector and the broader market by a wide margin.
Read full news article
Broad-Based Technical Strength Lifts Trident Lifeline Ltd to 52-Week High of Rs 330
2026-09-21 09:56:04Surging to an intraday peak of Rs 330 on 21 Sep 2026, Trident Lifeline Ltd has marked a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.
Read full news article
Trident Lifeline Ltd is Rated Hold
2026-09-16 10:10:03Trident Lifeline Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Trident Lifeline Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-09-16 08:02:05Trident Lifeline Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent 6.1% decline in its share price. This micro-cap pharmaceutical and biotechnology company now presents a compelling price-to-earnings (P/E) and price-to-book value (P/BV) profile relative to its peers and historical benchmarks, signalling a potential opportunity for investors seeking value in a challenging sector environment.
Read full news article
Trident Lifeline Ltd Valuation Shifts Signal Renewed Investor Interest
2026-09-07 08:01:04Trident Lifeline Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid sector-wide valuation trends and peer comparisons, with the stock currently trading at ₹293.30, up 7.55% on the day.
Read full news article
Trident Lifeline Ltd is Rated Hold by MarketsMOJO
2026-09-05 10:10:16Trident Lifeline Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 10 August 2026. While this rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 05 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news articleClarification sought from Trident Lifeline Ltd
23-Sep-2026 | Source : BSEThe Exchange has sought clarification from Trident Lifeline Ltd on September 23 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Sep-2026 | Source : BSEPursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure requirements) Regulation 2015 (the Listing Regulations) we wish to inform that the management of the Company will be participating in the Virtual Conference (group meeting) organized by Arihant Capital.
Disclosure Under Regulation 30 Of SEBI (LODR)- Intimation Of Award
08-Sep-2026 | Source : BSEWith reference to the above-captioned subject we are pleased to inform you that Trident Lifeline Limited has been honoured by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) for its outstanding contribution to Indias Pharmaceutical Exports during the year 2024-25
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







